Product Highlight - Boostrix

Indication: Boostrix is indicated for booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of four years onwards.

Boostrix is also indicated for passive protection against pertussis in early infancy following maternal immunisation during pregnancy.

Dosage & Administration: A single 0.5 mL dose of the vaccine is recommended.
• Boostrix is for deep intramuscular injection, preferably in the deltoid region.
• Boostrix can be administered to pregnant women during the second or the third trimester in accordance with official recommendations.
• Boostrix may be administered to adolescents and adults with unknown vaccination status or incomplete vaccination against diphtheria, tetanus and pertussis as part of an immunisation series against diphtheria, tetanus and pertussis. Based on data in adults, two additional doses of a diphtheria and tetanus containing vaccine are recommended one and six months after the first dose to maximize the vaccine response against diphtheria and tetanus.
• Repeat vaccination against diphtheria, tetanus and pertussis should be performed at intervals as per official recommendations (generally 10 years).